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The aim of our study was to analyse a significance of
tumour necrosis factor (TNF)-a promoter gene poly-
morphisms in relation to the HLA-DR locus in genetic
predisposition to pemphigus. TNF-a gene poly-
morphisms in position 
/238 and 
/308 were identi-
fied using a modified polymerase chain reaction-
restriction fragment length polymorphism method
in 53 patients with pemphigus (38 with pemphigus
vulgaris, 15 with pemphigus foliaceus) and 87
healthy controls. The HLA-DRB1 locus was typed
using the polymerase chain reaction SSO method in
all the patients and 152 population controls.
Carriers of the TNF-a polymorphic 
/308 A allele were
found to be more frequent in the pemphigus folia-
ceus group in comparison with the control group
(odds ratio (OR)/8.12; p/0.0005). A significant
association between HLA-DRB1*04 (OR/3.86;
pcor/0.0001) and DRB1*14 (OR/8.4; pcor/
0.0001) and pemphigus vulgaris was found. In this
group of patients a decreased frequency of HLA-
DRB1*07 (OR/0.08; pcor/0.006) was also identi-
fied.
We have shown for the first time a positive associa-
tion of TNF-a polymorphism in position 
/308 with
pemphigus foliaceus.
Key words: Polymorphism tumour necrosis factor-a, HLA
class II, Pemphigus vulgaris, Pemphigus foliaceus, Polish
population
Mediators of Inflammation, 12(5), 303/307 (October 2003)
Tumour necrosis factor-a
polymorphism as one of the













1Department of Dermatology and
2Department of
Clinical Immunology and Allergy, Medical University
of Lodz, Krzemieniecka 5, 94-017 Lodz, Poland
CACorresponding author
Tel/fax:  /48 42 688 45 65
E-mail: torzecka@poczta.onet.pl
Introduction
Pemphigus is an autoimmune disease, clinically
characterized by bullae and erosions on the skin
and mucous membranes. The aetiopathogenesis of
pemphigus is not fully elucidated; however, addi-
tionally to an autoimmunological background, cer-
tain environmental agents such as medications,
ultraviolet irradiation, diet, and viral infections are
regarded as triggering factors, especially in geneti-
cally susceptible individuals. Two major forms of
pemphigus, pemphigus vulgaris (PV) and pemphigus
foliaceus (PF), based on the clinical picture, histolo-
gical and immunological examinations are distin-
guished. In PF patients circulating IgG
autoantibodies are directed against desmoglein 1
(Dsg 1) solely, while in PV antibodies are detected
against desmoglein 3 (Dsg 3) sometimes in combina-
tion with anti-Dsg 1.
Studies on immunogenetic background in pem-
phigus have so far focused on association between
the disease and certain HLA antigens. We have not
found any literature data analysing other genetic
factors involved in immune response in pemphigus.
Tumour necrosis factor (TNF)-a is a proinflamma-
tory cytokine that plays a key role in the pathogenesis
of many infections and inflammatory diseases. The
TNF-a gene is located within the class III region of
the human HLA locus and several studies have shown
extensive linkage disequilibrium both within the TNF
locus and HLA class I and II. Several polymorphisms
in the TNF-a gene were found to be associated with
various autoimmune disorders. Elevated levels of
TNF-a mRNA and protein have been demonstrated
in skin and sera of patients with pemphigus vul-
garis.
1,2 Additionally, TNF-a receptor-deficient mice
demonstrated a decreased susceptibility to pemphi-
gus development after passive transfer of IgG auto-
antibodies.
1 TNF-a gene polymorphism in
pemphigus patients has not so far been studied.
Literature data highlight a strong association be-
tween the disease and HLA class II locus. Associa-
tions of HLA-DRB1*0402, DRB1*1401 and DQB1*0503
alleles with pemphigus vulgaris were reported in
Jewish, non-Jewish and Japanese populations.
36
Interestingly, it has been shown that autoreactive T
cells from PV patients recognize certain Dsg 3
fragments in restriction to HLA-DRB1*0402 and
DQB1*0503.
7 Similarly, in PF patients associations
with HLA-DRB1*04, DRB1*14 and DRB1*16 were
identified,
8 and direct involvement of these HLA
molecules in presentation of desmoglein 1 fragments
was suggested.
9 There are many reports on HLA
alleles profile in pemphigus in various populations
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303(Spanish, French, Italian, etc.); however, studies
including exclusively Polish patients have not so far
been performed.
In order to analyse a significance of TNF-a gene
polymorphism in genetic predisposition to pemphi-
gus, we designed an association study in a group of
patients with PV and PF in Polish population,
genotyped for HLA-DRB1.
Materials and methods
Our study comprised 53 patients with pemphigus (38
with PV, 15 with PF), 26 males and 27 females, with a
mean age of 53.9 years. In all the patients the
diagnosis was confirmed by histological and immu-
nological examinations (direct and indirect immuno-
fluorescence tests).
Genomic DNA was extracted from peripheral
blood cells using the ‘Easy Blood DNA Prep’ (A&A
Biotechnology, Gdynia, Poland). TNF-a gene poly-
morphisms in positions /238 and /308 were identi-
fied using the modified polymerase chain reaction
(PCR)/restriction fragment length polymorphism/
amplification created restriction sites method
10 in
the patients and in 87 unrelated healthy individuals
from the members of the organ donors’ families. The
117 base pair PCR fragment was amplified using Taq
Polymerase (Rapidozym, Berlin, Germany) and mod-
ified primers introducing the NcoI restriction site for
G in position /308 and the AvaII restriction site for G
in position /238. After digestion the obtained frag-
ments were detected in a 4% agarose gel, stained with
ethidium bromide and visualized under ultraviolet
illumination.
Molecular typing of groups of HLA-DRB alleles at a
low-resolution level in the patients and 152 healthy
unrelated individuals was carried out using the Dynal
RELI SSO HLA-DRB Test (Dynal Biotech A.S.A., Oslo,
Norway) set of 36 molecular probes. Polymorphic
fragments (second exon) of genes DRB1, DRB3,
DRB4 and DRB5 were amplified in PCR reaction: 35
cycles of 15 sec at 958C, 45 sec at 608C, 15 sec at 728C
and 5 min at 728C, using Taq polymerase and PCR
buffer (Rapidozym, Berlin, Germany). After denatura-
tion the PCR products were hybridized in SSPE buffer
at 508C with a set of specific molecular probes
coating nylon stripes. The reaction results were
read using the system of horseradish streptavidin-
peroxidase. The results of typing were analysed using
the Dynal RELI SSO Pattern Matching Program.
The study protocol was approved by the Ethics
Committee of the Lodz Medical University. All sub-
jects gave written informed consent before entering
the study.
Statistical analysis
The frequencies of HLA-DRB and TNF-a poly-
morphic alleles in patients and controls were com-
pared using the two-sided Fisher’s exact test. The
significance in the genotype frequency differences
between patients and controls was evaluated using
the x
2 (two degrees of freedom) test. Values of p B/
0.05 was considered statistically significant. To cor-
rect for incidental significance, the p value was
multiplied by the number of alleles compared
(pcor). An odds ratio (OR) was calculated as the
cross product in a 2/2 table within 95% confidence
intervals (95% CI).
Results
The distribution of polymorphism of TNF-a in posi-
tions /238 and /308 in PV and PF is presented in
Table 1. Carriers of allele A in position /308 were
found to be more frequent in patients with PF in
comparison with the control group (p/0.0005,
OR/8.12, 95% CI/2.34/28.1). The A-allele fre-
quency was also higher in PF patients (40%) versus
controls (13.2%) (p/0.001, OR/4.79, 95% CI/
2.02/11.34). No significant differences in /308
TNF-a polymorphism distribution between the PV
and the control groups were observed. TNF-a poly-
morphism in position /238 was not significantly
associated with either PV or PF.
The results of HLA-DR analysis in PV and PF
patients are presented in Table 2.
PV patients showed a statistically significant asso-
ciation with HLA-DRB1*04 (OR/3.86, pcor/
0.0001) and DRB1*14 (OR/8.4, pcor/0.0001).
Also in this group we found a statistically significant
decreased frequency of HLA-DRB1*07 (OR/0.08,
pcor/0.006) when compared with the control group
(Table 2). No statistically significant differences
between frequencies of HLA-DR alleles in patients
with PF and the control group were identified.
Discussion
TNF-a is one of the mediators involved in inflamma-
tory processes. Its production can be regulated at the
transcriptional, post-transcriptional and translational
levels. Variability in the promoter and coding regions
of the TNF-a gene may modulate the magnitude of its
secretory response. The results of the in vivo studies
demonstrated that PV-IgG autoantibodies induced
TNF-a mRNA in the skin. Some authors found over
expression of this cytokine in the lesions in the
pemphigus patients and the correlation between its
serum level and the disease activity.
2 These observa-
tions suggest the role of this mediator in the devel-
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damage.
We found a significant association of the TNF-a
/308 A allele with PF and, interestingly, no such a
relation in a group of patients with PV was observed.
There was no significant association of pemphigus
phenotypes with the polymorphism in position /238
as well. The group of PF patients is rather small, but
most of our PF patients (11/15, 73%) were carriers of
at least one /308 A allele. At this stage the relevance
of this association is difficult to explain. It might result
from strong linkage disequilibrium between HLA and
TNF-a loci. It has been reported that the TNF-a /308
A allele is in linkage with the HLA-A1/B8/DR3
haplotype,
11 but no such HLA association with PF
has yet been identified, which makes this hypothesis
less probable. Another possibility may be related to
direct involvement of TNF-a in pathomechanism of
PF. The TNF-a /308 polymorphism has been shown
to alter function and has been associated with a six-
fold to seven-fold higher level of transcription of
TNF-a.
12 Other studies, however, have failed to show
any functional change associated with this poly-
morphism.
13 In vivo studies have also shown con-
flicting results, with Chen et al.
14 and Juszczynski et
al.
15 finding high levels of TNF-a associated with the
/308 G/A polymorphism, while others reported no
significant association between /308 polymorphism
and TNF-a levels.
16 Thus, our preliminary observa-
tion of positive association between the TNF-a locus








n % n % n % PV versus controls PF versus controls
/238 genotypes
GG 37 97.4 13 86.5 83 95.4 NS NS
GA 1 2.6 1 6.75 4 4.5
AA 0 0 1 6.75 0 0
G carriers 37 97.4 13 86.5 83 95.4 NS NS
A carriers 1 2.6 2 13.5 0 0 NS NS
/238 alleles n/76 n/30 n/174
G 75 98.7 27 90 170 97.7 NS NS
A 1 1.3 3 10 4 2.3 NS NS
/308 genotypes
GG 33 86.9 4 26.7 65 74.7 NS p/0.002
GA 4 10.5 10 66.7 21 24.1
AA 1 2.6 1 6.6 1 1.2
G carriers 33 86.9 4 26.7 65 74.7 NS p/0.0005
A carriers 5 13.1 11 73.3 22 25.3 NS p/0.0005*, OR/8.12, 95%
CI/2.34/28.1
/308 alleles n/76 n/30 n/174
G 70 92.1 18 60 151 86.8 NS p/0.001
A 6 7.9 12 40 23 13.2 NS p/0.001*, OR/4.79, 95%
CI/2.02/11.34
* Statistically significant. NS, non-statistically significant.








n % n % n % PV versus controls PF versus controls
*01 8 10.5 7 23.3 31 10.2 NS NS
*15/16 5 6.6 2 6.7 51 16.8 NS NS
*03 3 3.9 8 26.7 31 10.2 NS pB/0.01, pcor/NS
*04 27 35.5 5 16.7 38 12.5 pB/0.0001*, pcor/0.0001,
OR/3.86, 95% CI/2.16/6.89
NS
*07 1 1.3 3 10 44 14.5 p/0.0005*, pcor/0.006,
OR/0.08, 95% CI/0.01/0.58
NS
*08 2 2.6 1 3.3 7 2.3 NS NS
*09 2 2.6 0 3 1 NS NS
*10 0 0 7 2.3 NS NS
*11 11 14.5 3 10 42 13.8 NS NS
*12 0 0 14 4.6 NS NS
*13 6 79 1 3.3 30 9.9 NS NS
*14 11 14.5 0 6 2 pB/0.0001*, pcor/0.0001,
OR/8.4, 95% CI/2.99/23.5
NS
* Statistically significant. NS, non-statistically significant.
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directly involved in the pathomechanism of PF or
may be related to differential clinical manifestation of
various types of pemphigus. A similar role of the
TNF-a polymorphism has been suggested in other
autoimmune diseases like rheumatoid arthritis or
systemic lupus erythematosus.
17,18 Based on the
presented data we conclude that TNF-a polymorph-
ism is part of the complex inherited factors in
pemphigus.
The role of the genetic background, including
mainly HLA class II genes is strongly stressed in the
pathogenesis of pemphigus. Many authors have
shown that HLA-DR*04 and DR*14 confer strong




5,6 Our studies con-
ducted in Polish pemphigus patients confirmed these
observations. The frequency of both HLA-DRB1*04
and DRB1*14 alleles were significantly higher in
patients with PV than in an ethnically matched
control group. Current evidence indicates that Dsg
3 is the dominant initial autoantigen in PV and that
anti-Dsg 3 antibodies produced in restriction to HLA-
DRB1*0402 and DQB1*0503 (in strong linkage dis-
equilibrium with DRB1*1401) induce lesion forma-
tion. It has been shown that only antigen presenting
cells expressing HLA-DRB1*0402 and DQB1*0503
were capable of presenting Dsg 3 to autoreactive
Th1 and Th2 clones, stressing a direct involvement of
particular HLA antigens in the pathomechanism of
PV.
7
The relationship between PF and HLA class II locus
is less clear. Lombardi et al.
19 and Miyagawa et al.
20
indicated that HLA-DRB1*04 and HLA-DRB1*14 are
also associated with PF but in our study group we did
not find such an association. In the case of the
endemic form of PF (fogo selvagem), it has been
shown that the autoimmune proliferative T-cell
response is directed to external fragment of Dsg 1
in restriction to certain HLA alleles, mainly
DRB1*0404, DRB1*1402, DRB1*1406 and
DRB1*1602, which share the same sequence (LLEQR-
RAA) in the DRB hypervariable domain from amino
acids 67 to 74.
9 The study performed by Moraes et
al.
8 in three different Brazilian populations with FS
showed positive association with HLA-DRB1*01,
DRB1*04 and DRB1*14, which suggests that a similar
pathomechanism as in PV may apply to fogo
selvagem and possibly to PF as well. The fact that
presentation of causative autoantigens in PF may be
restricted by several HLA alleles might explain lack of
significant positive associations found in our study.
Further studies on bigger groups with PF are required
to demonstrate such associations with the HLA locus.
In accordance with an idea of direct presentation
of pemphigus autoantigens by certain HLA alleles, a
negative association of HLA with pemphigus may
occur, related to insufficient presentation of these
antigens in restriction to some other HLA alleles. The
significantly decreased frequency of HLA-DRB1*07
observed in our patients, similar to the results of HLA
analysis in Italian and Brazilian patients with PV and
PF,
19,21 suggest its protective role against pemphigus
development. Other studies have also shown that
certain HLA alleles play a protective role; for exam-
ple, in Spanish patients with PV (DRB1*13)
22 and in
Turkish patients (DR 11, DQ 7 and DQ 2).
23
In conclusion, we have shown a positive associa-
tion of TNF-a polymorphism in position /308 with
PF for the first time. We also show that the same
association of HLA-DR*04 and DR*14 alleles with PV,
as reported before in other ethnic groups, is also
present in Polish pemphigus patients. Although TNF-
a and HLA-DR genes may play a role in pemphigus
development, the genetic association of TNF-a poly-
morphism with pemphigus seems to be independent
of the HLA class II antigens.
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